Award
Award 36C25721N0675 — EXACT SCIENCES CORPORATION
- Awarded to
- EXACT SCIENCES CORPORATION
- Agency
- Department of Veterans Affairs
- Estimated value
- $82,373
ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Key dates
- Award date
- September 18, 2021
- Performance start
- September 18, 2021
- Performance end
- September 17, 2025
Who is this buyer
Organization
Buying history
- Records404 total
- Opportunities / awards5 / 264
- Value range$0 – $35,722,589
- ActiveMay 1, 2026 – October 26, 2026
What they buy
- Clinical (365)
- Administrative (39)
Set-asides used
- SDVOSB Set-Aside (FAR 19.14) (30)
- Small Business Set Aside - Total (25)
- No Set aside used (18)
- SDVOSB Sole Source (FAR 19.14) (7)
Who holds their work today
- PRIMARY CARE SOLUTIONS INC10 wins · $44,012,982 · last October 1, 2026
- VALOR HEALTHCARE INC9 wins · $38,463,715 · last September 13, 2026
- POTOMAC VALOR HEALTHCARE 2, LLC6 wins · $35,632,398 · last August 12, 2026
- QUEST DIAGNOSTICS INCORPORATED16 wins · $15,161,389 · last June 1, 2026
- JADE WOLF OPERATIONS, LLC1 win · $14,351,033 · last March 1, 2023
Also open from this buyer
- Sources Sought Notice - Ga68 Dotatate (NETSPOT)Due October 30, 2026 · Clinical
- NEW – STX Specialized Molecular Residual Disease TestingDue October 30, 2026 · Clinical
- Sterile Compounding ServicesDue November 4, 2026 · Clinical
- SterilizerDue November 3, 2026 · Clinical
View source document →
Source link on usaspending.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 621511
- PSC
- Q301